MEDICINA
Departamento
University of Leeds
Leeds, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Leeds (20)
2023
-
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
The Lancet Oncology, Vol. 24, Núm. 6, pp. e255-e269
2022
-
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322
Annals of oncology : official journal of the European Society for Medical Oncology
-
Corrigendum: “Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’”: (Annals of Oncology (2022) 33(1) (117), (S0923753421044999), (10.1016/j.annonc.2021.10.001))
Annals of Oncology
2021
-
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
The Lancet Haematology, Vol. 8, Núm. 12, pp. e934-e946
-
Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
HemaSphere, Vol. 5, Núm. 2
-
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Annals of Oncology, Vol. 32, Núm. 3, pp. 309-322
2020
-
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set
Blood, Vol. 136, Núm. 26, pp. 3033-3040
-
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: Subgroup analysis of the phase 3 CASTOR and POLLUX studies
Haematologica, Vol. 105, Núm. 2, pp. 468-477
2019
-
Chimeric antigen receptor T-cell therapy for multiple myeloma: A consensus statement from the European Myeloma Network
Haematologica, Vol. 104, Núm. 12, pp. 2358-2360
2018
-
Maintenance Treatment and Survival in Patients with Myeloma: A Systematic Review and Network Meta-analysis
JAMA Oncology, Vol. 4, Núm. 10, pp. 1389-1397
2016
-
Addressing misuse and diversion of opioid substitution medication: Guidance based on systematic evidence review and real-world experience
Journal of Public Health (United Kingdom), Vol. 38, Núm. 3, pp. e368-e374
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
2015
-
The extent of misuse and diversion of medication for agonist opioid treatment: A review and expert opinions
Heroin Addiction and Related Clinical Problems, Vol. 17, Núm. 2-3, pp. 25-34
2012
-
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
Leukemia, Vol. 26, Núm. 9, pp. 1908-1975
-
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
Leukemia, Vol. 26, Núm. 9, pp. 1986-2010
2009
-
The use of bisphosphonates in multiple myeloma: Recommendations of an expert panel on behalf of the European Myeloma Network
Annals of Oncology, Vol. 20, Núm. 8, pp. 1303-1317
2007
-
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
Blood, Vol. 110, Núm. 9, pp. 3112-3121
-
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: - Report of the BIOMED-2 Concerted Action BHM4-CT98-3936
Leukemia, Vol. 21, Núm. 2, pp. 201-206
2004
-
Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report
Cancer Research